Evidence map›Paper›PMID 40978732›Full record

ArticleFrontiers in medicine2025

The early bird in renal rescue: timing matters in acute kidney injury management-insights from target trial emulation.

Miaowen She, Jinhu Zhuang, Xi Chen, Lili Hu, Thuan-Quoc Thach, Kin Cheung, Xiaxia Yu, Mengyi Wang, Xiang Zheng, Yong Liu

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Miaowen SheDepartment of Critical Care Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
Jinhu ZhuangShenzhen Health Development Research and Data Management Center, Shenzhen, China.
Xi ChenDepartment of Pharmacy, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
Lili HuIntensive Care Unit, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
Thuan-Quoc ThachDepartment of Psychiatry, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
Kin CheungSchool of Nursing, The Hong Kong Polytechnic University, Hong Kong, China.
Xiaxia YuSchool of Biomedical Engineering, Shenzhen University Medical School, Shenzhen University, Shenzhen, China.
Mengyi WangIntensive Care Unit, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
Xiang ZhengDepartment of Critical Care Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
Yong LiuIntensive Care Unit, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Acute kidney injury (AKI) is prevalent in critically ill patients. The optimal timing for initiating renal replacement therapy (RRT) remains unsettled. Clinical intuition suggests early initiation could be beneficial, but evidence from studies is inconsistent. Methods: A target trial emulation was conducted using the Medical Information Mart for Intensive Care-IV (MIMIC-IV) database. Two cohorts were analyzed: broader cohort (stage ≥1, Results: In the broader cohort, early initiation was associated with lower 90-day (hazard ratio (HR): 0.653, 95% confidence interval (CI): 0.512-0.834) and 30-day mortality (HR 0.649, 95% CI 0.504-0.835). However, accelerated failure time models indicated no survival benefit and potentially worse outcomes, with a 14.8% reduction in 90-day survival and a 14.1% reduction in 30-day survival. Augmented inverse probability weighting (AIPW) analysis further confirmed these findings, showing a risk difference of 2.6 percentage points between early and late initiation of RRT. In the severe cohort, early initiation was associated with lower 90-day mortality (HR: 0.561, 95% CI: 0.341-0.921) and 30-day mortality (HR: 0.604, 95% CI: 0.357-1.022), with accelerated failure time models confirming longer survival. Augmented inverse probability weighting analysis in this group showed a risk difference of 1.7 percentage points. Conclusion: Early initiation appears beneficial in the severe cohort (stage 3), but not in the broader cohort (stage ≥1), where it could even be harmful. This highlights the need for personalized treatment based on the severity of acute kidney injury and further research to optimize the timing of renal replacement therapy.

Indexed as

acute kidney injurymortalityrenal replacement therapytarget trial emulationtiming

Identifiers

PMID40978732
PMCPMC12443691

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.